Latest Breaking News On - Mirati therapeutics inc - Page 5 : comparemela.com

Fiera Capital Corp Acquires 346,803 Shares of Mirati Therapeutics, Inc (NASDAQ:MRTX)

Fiera Capital Corp Acquires 346,803 Shares of Mirati Therapeutics, Inc (NASDAQ:MRTX)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesBenjamin hickeyJamie christensenLeerink partnrsStifel nicolausMirati therapeutics incVanguard group incFiera capital corpBlackrock incMirati therapeutics company profileGoldman sachs group incMirati therapeuticsFree reportCapital corpStreet corpSachs group

Brokerages Set Mirati Therapeutics, Inc (NASDAQ:MRTX) Price Target at $60 00

Shares of Mirati Therapeutics, Inc. (NASDAQ:MRTX – Get Free Report) have earned an average recommendation of “Hold” from the fourteen brokerages that are currently covering the firm, MarketBeat Ratings reports. Eleven analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 1 year price […]

United statesJamie christensenLeerink partnrsBenjamin hickeyStifel nicolausAcadian asset managementMirati therapeutics incQuadrant capital groupBluepath capital managementSecurities exchange commissionFirst horizon advisors incMirati therapeuticsGet free reportMarketbeat ratingsExchange commissionCapital group

Joe Lewis $7 6 Billion Global Empire Weathers His Biggest Test

Joe Lewis $7 6 Billion Global Empire Weathers His Biggest Test
bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.

Western australiaBroad bayEilean siarUnited kingdomSan diegoUnited statesNew yorkBrad bondiSidley austinCohen gresserBloomberg joe lewiAllon lifshitzDaniel levyHoldings plcMirati therapeutics incNew york times

Bristol Sees New Drugs Fueling Optimistic 2024 Profit Outlook

Bristol Sees New Drugs Fueling Optimistic 2024 Profit Outlook
bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesAdam lenkowskyRayzebio incBloomberg bristol myers squibb coMirati therapeutics incPfizer incKaruna therapeutics incMyers squibbWall streetMirati therapeuticsKaruna therapeuticsChief commercialization officer adam lenkowsky

StockNews com Initiates Coverage on Mirati Therapeutics (NASDAQ:MRTX)

StockNews.com began coverage on shares of Mirati Therapeutics (NASDAQ:MRTX – Free Report) in a research note released on Tuesday. The brokerage issued a sell rating on the biotechnology company’s stock. Several other analysts have also recently commented on MRTX. Piper Sandler cut shares of Mirati Therapeutics from an overweight rating to a neutral rating and […]

United statesJamie christensenBenjamin hickeyLeerink partnrsPiper sandlerUs bancorpMirati therapeutics incBlackrock incSecurities exchange commissionAcadian asset managementAdvisor group holdings incMirati therapeutics company profileMetlife investment managementMirati therapeuticsFree reportTherapeutics trading down